Matches in SemOpenAlex for { <https://semopenalex.org/work/W2971036334> ?p ?o ?g. }
- W2971036334 endingPage "421" @default.
- W2971036334 startingPage "421" @default.
- W2971036334 abstract "Various glutamate urea ligands have displayed high affinities to prostate specific membrane antigen (PSMA), which is highly overexpressed in prostate and other cancer sites. The multivalent versions of small PSMA-targeted molecules are known to be even more efficiently bound to the receptor. Here, we employ a well-known urea-based ligand, 2-[3-(1,3-dicarboxypropyl)-ureido] pentanedioic acid (DUPA) and triazine dendrimers in order to study the effect of molecular size on multivalent targeting in prostate cancer. The synthetic route starts with the preparation of a dichlorotriazine bearing DUPA in 67% overall yield over five steps. This dichlorotriazine reacts with G1, G3, and G5 triazine dendrimers bearing a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) group for 64Cu-labeling at the core to afford poly(monochlorotriazine) intermediates. Addition of 4-aminomethylpiperidine (4-AMP) and the following deprotection produce the target compounds, G1-(DUPA)4, G3-(DUPA)16, and G5-(DUPA)64. These targets include 4/16/64 DUPA groups on the surface and a DOTA group at the core, respectively. In vitro cell assay using PC3-PIP (PSMA positive) and PC3-FLU (PSMA negative) cells reveals that G1-(DUPA)4 has the highest PC3-PIP to PC3-FLU uptake ratio (10-fold) through the PSMA-mediated specific uptake. While G5-(DUPA)64 displayed approximately 12 times higher binding affinity (IC50 23.6 nM) to PC3-PIP cells than G1-(DUPA)4 (IC50 282.3 nM) as evaluated in a competitive binding assay, the G5 dendrimer also showed high non-specific binding to PC3-FLU cells. In vivo uptake of the 64Cu-labeled dendrimers was also evaluated in severe combined inmmunodeficient (SCID) mice bearing PC3-PIP and PC3-FLU xenografts on each shoulder, respectively. Interestingly, quantitative imaging analysis of positron emission tomograph (PET) displayed the lowest tumor uptake in PC3-PIP cells for the midsize dendrimer G3-(DUPA)16 (19.4 kDa) (0.66 ± 0.15%ID/g at 1 h. p.i., 0.64 ± 0.11%ID/g at 4 h. p.i., and 0.67 ± 0.08%ID/g at 24 h. p.i.). Through the specific binding of G1-(DUPA)4 to PSMA, the smallest dendrimer (5.1 kDa) demonstrated the highest PC3-PIP to muscle and PC3-PIP to PC3-FLU uptake ratios (17.7 ± 5.5 and 6.7 ± 3.0 at 4 h p.i., respectively). In addition, the enhanced permeability and retention (EPR) effect appeared to be an overwhelming factor for tumor uptake of the largest dendrimer G5-(DUPA)64 as the uptake was at a similar level irrelevant to the PSMA expression." @default.
- W2971036334 created "2019-09-05" @default.
- W2971036334 creator A5015297002 @default.
- W2971036334 creator A5018353132 @default.
- W2971036334 creator A5041524172 @default.
- W2971036334 creator A5070272648 @default.
- W2971036334 creator A5073466957 @default.
- W2971036334 creator A5073800181 @default.
- W2971036334 date "2019-08-28" @default.
- W2971036334 modified "2023-09-26" @default.
- W2971036334 title "Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting" @default.
- W2971036334 cites W1786020367 @default.
- W2971036334 cites W1967870961 @default.
- W2971036334 cites W1969471545 @default.
- W2971036334 cites W1973773389 @default.
- W2971036334 cites W1975473350 @default.
- W2971036334 cites W1980612042 @default.
- W2971036334 cites W1982551773 @default.
- W2971036334 cites W1989377456 @default.
- W2971036334 cites W1990455420 @default.
- W2971036334 cites W1994430461 @default.
- W2971036334 cites W2005768891 @default.
- W2971036334 cites W2011660334 @default.
- W2971036334 cites W2037048276 @default.
- W2971036334 cites W2038813477 @default.
- W2971036334 cites W2038974491 @default.
- W2971036334 cites W2041914114 @default.
- W2971036334 cites W2046851174 @default.
- W2971036334 cites W2069086041 @default.
- W2971036334 cites W2094194375 @default.
- W2971036334 cites W2096961884 @default.
- W2971036334 cites W2097585139 @default.
- W2971036334 cites W2097629605 @default.
- W2971036334 cites W2098798452 @default.
- W2971036334 cites W2105337740 @default.
- W2971036334 cites W2116511683 @default.
- W2971036334 cites W2117680513 @default.
- W2971036334 cites W2118167053 @default.
- W2971036334 cites W2120873855 @default.
- W2971036334 cites W2125363072 @default.
- W2971036334 cites W2129360146 @default.
- W2971036334 cites W2133777928 @default.
- W2971036334 cites W2134364976 @default.
- W2971036334 cites W2135486162 @default.
- W2971036334 cites W2145102538 @default.
- W2971036334 cites W2153935963 @default.
- W2971036334 cites W2156969927 @default.
- W2971036334 cites W2229603522 @default.
- W2971036334 cites W2287868019 @default.
- W2971036334 cites W2304896218 @default.
- W2971036334 cites W2313449790 @default.
- W2971036334 cites W2316400334 @default.
- W2971036334 cites W2328150073 @default.
- W2971036334 cites W2414807800 @default.
- W2971036334 cites W2586797632 @default.
- W2971036334 cites W2735353052 @default.
- W2971036334 cites W2750406476 @default.
- W2971036334 cites W2754938970 @default.
- W2971036334 cites W2781525129 @default.
- W2971036334 cites W2793546593 @default.
- W2971036334 cites W2798266177 @default.
- W2971036334 cites W2884452804 @default.
- W2971036334 doi "https://doi.org/10.3390/biom9090421" @default.
- W2971036334 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6770530" @default.
- W2971036334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31466360" @default.
- W2971036334 hasPublicationYear "2019" @default.
- W2971036334 type Work @default.
- W2971036334 sameAs 2971036334 @default.
- W2971036334 citedByCount "14" @default.
- W2971036334 countsByYear W29710363342019 @default.
- W2971036334 countsByYear W29710363342020 @default.
- W2971036334 countsByYear W29710363342021 @default.
- W2971036334 countsByYear W29710363342022 @default.
- W2971036334 countsByYear W29710363342023 @default.
- W2971036334 crossrefType "journal-article" @default.
- W2971036334 hasAuthorship W2971036334A5015297002 @default.
- W2971036334 hasAuthorship W2971036334A5018353132 @default.
- W2971036334 hasAuthorship W2971036334A5041524172 @default.
- W2971036334 hasAuthorship W2971036334A5070272648 @default.
- W2971036334 hasAuthorship W2971036334A5073466957 @default.
- W2971036334 hasAuthorship W2971036334A5073800181 @default.
- W2971036334 hasBestOaLocation W29710363341 @default.
- W2971036334 hasConcept C116569031 @default.
- W2971036334 hasConcept C153911025 @default.
- W2971036334 hasConcept C170493617 @default.
- W2971036334 hasConcept C178790620 @default.
- W2971036334 hasConcept C185592680 @default.
- W2971036334 hasConcept C202751555 @default.
- W2971036334 hasConcept C21951064 @default.
- W2971036334 hasConcept C2776303721 @default.
- W2971036334 hasConcept C2777752497 @default.
- W2971036334 hasConcept C502942594 @default.
- W2971036334 hasConcept C55493867 @default.
- W2971036334 hasConcept C55637122 @default.
- W2971036334 hasConcept C71240020 @default.
- W2971036334 hasConcept C86803240 @default.
- W2971036334 hasConceptScore W2971036334C116569031 @default.
- W2971036334 hasConceptScore W2971036334C153911025 @default.